Skip to content
How It Works
Explore
Ask a Question Resources Pricing
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Ask a Question
PubMed This is a summary of 18 peer-reviewed journal articles Updated
Cardiology · Essential Hypertension

Checking for Silent Organ Damage (HMOD)

At a Glance

High blood pressure can silently strain the heart and kidneys. An ECG, kidney filtration estimate, urine protein test, and basic blood tests can detect organ changes and help clinicians set personalized blood pressure goals and treatment.

While the number on a blood pressure monitor is important, it is only one part of the story. A critical step in your long-term health is evaluating whether high blood pressure has begun to change the structure or function of your body’s vital organs [1][2]. These changes are called Hypertension-Mediated Organ Damage (HMOD) [3].

HMOD often happens silently, meaning you cannot feel it [4]. However, detecting it early is essential because people with HMOD have a higher risk of cardiovascular events than those with the same blood pressure but no organ damage [1][5].

Common Baseline Tests

While local practices vary, international guidelines commonly recommend that people newly diagnosed with hypertension undergo a basic set of tests to map out their health before or while starting treatment [1][6]. Your doctor will individualize these based on your history and risk:

  • 12-Lead ECG (Electrocardiogram): A simple, painless test that records the electrical activity of your heart [7].
  • Serum Creatinine and eGFR: A blood test used to calculate how well your kidneys are filtering waste [8].
  • Urine ACR (Albumin-to-Creatinine Ratio): A urine test that checks for small amounts of protein leaking from your kidneys [1][8]. (A first-morning sample is preferred, but a random sample is often used).
  • Basic Labs: Testing for electrolytes (sodium and potassium), blood sugar or HbA1c (to check for diabetes), a cholesterol panel, and sometimes a complete blood count or thyroid test [6].

Looking for the Heart’s Response: The ECG

High blood pressure forces your heart to work harder to push blood throughout your body. Over time, the heart muscle may thicken to handle this extra load, a condition called left ventricular hypertrophy (LVH) [5][1].

Your doctor uses an ECG to look for specific electrical patterns that suggest the heart muscle might be getting thicker [7][9]. It is important to know that while an ECG can suggest thickening, it does not definitively prove it. If the ECG is abnormal, or if clinically indicated, your doctor may order an ultrasound of the heart (echocardiogram) to get a much more accurate look at the heart’s size and function [10][11].

Testing the “Filters”: eGFR and Urine ACR

Your kidneys are highly sensitive to high blood pressure. Because they are filled with tiny, delicate blood vessels, they are often the first organs to show strain [12]. Doctors use two different numbers to check your kidney health:

  1. eGFR (Estimated Glomerular Filtration Rate): This number tells your doctor roughly how much blood your kidneys are filtering per minute. A lower-than-normal number suggests your “filters” may be slowing down [8][13].
  2. Urine ACR (Albuminuria): This test looks for a protein called albumin in your urine. Healthy kidneys keep protein in the blood; if albumin is leaking into your urine, it can be an early warning sign that the kidney’s filters are being stressed [1][14].
ACR Category What it Means [15]
A1 (<30 mg/g) Normal to mildly increased
A2 (30–299 mg/g) Moderately increased (Early warning sign)
A3 (≥300 mg/g) Severely increased (Significant leakage)

Because protein levels can fluctuate due to exercise, fever, or infection, a single abnormal ACR result does not confirm permanent damage. Your doctor will usually repeat the test to see if the issue persists [16][17].

Why These Results Matter for Your Care

Identifying signs of organ strain shifts the focus of your treatment from just “lowering a number” to “protecting your organs” [2]. If HMOD or other risks are found, your doctor may recommend:

  • Individualized BP Goals: Your target blood pressure will be personalized based on your kidney health, diabetes status, age, and cardiovascular risk.
  • Targeted Medications: Certain drug classes are particularly helpful in specific settings. For example, ACE inhibitors or ARBs are strongly preferred if you have protein leaking into your urine (albuminuric kidney disease) [18].
  • Comprehensive Risk Management: Managing your cholesterol, blood sugar, and overall lifestyle becomes even more important to prevent future cardiovascular events [2][18].

Common questions in this guide

What is HMOD, and why does it matter if I have high blood pressure?
Hypertension-mediated organ damage, or HMOD, means that high blood pressure has begun to affect organs such as the heart or kidneys. It often causes no noticeable symptoms, but it is linked with a higher risk of cardiovascular problems and can change how your care is planned.
Which tests can check whether high blood pressure is affecting my organs?
Common baseline tests include a 12-lead ECG, blood creatinine with an estimated filtration rate, and a urine albumin-to-creatinine ratio. Doctors may also check electrolytes, blood sugar or HbA1c, cholesterol, and other labs based on your health history.
What do eGFR and urine ACR tell me about my kidneys?
eGFR estimates how well your kidneys filter waste from the blood. Urine ACR checks whether the protein albumin is leaking into your urine, which can signal stress on the kidney filters. An abnormal ACR is often repeated because exercise, fever, or infection can temporarily raise it.
Can high blood pressure make my heart muscle thicker?
Yes. Long-term high blood pressure can make the heart work harder and may lead to thickening of the main pumping chamber, called left ventricular hypertrophy. An ECG can suggest this change, while an echocardiogram provides a more accurate view of the heart's size and function.
What happens if testing finds organ damage from hypertension?
Your clinician may set a personalized blood pressure goal based on your kidney health, diabetes status, age, and overall cardiovascular risk. Treatment may include blood pressure medication, with ACE inhibitors or ARBs often favored when albumin is leaking into the urine, along with cholesterol, blood sugar, and lifestyle management.
Is a single abnormal urine ACR result proof of permanent kidney damage?
No. Albumin levels in urine can change temporarily because of exercise, fever, or infection. Your clinician will usually repeat the test to determine whether the finding persists.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Which baseline screenings for organ health—like an ECG, kidney labs, or urine tests—are appropriate for me right now?
  2. 2.What do my 'eGFR' and 'urine ACR' numbers say about my current kidney health?
  3. 3.Did my ECG show any signs of strain or thickening of my heart muscle?
  4. 4.Based on my test results and overall cardiovascular risk, what should my personalized target blood pressure be?
  5. 5.If there are signs of organ strain, how does that change the types of medication we should consider using?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (18)
  1. 1

    Selecting the optimal method for assessment of hypertension-mediated organ damage: a personalized approach.

    Gerdts E, Benetos A, Bruno RM, et al.

    European journal of preventive cardiology 2026; (33(7)):1021-1032 doi:10.1093/eurjpc/zwag052.

    PMID: 41603527
  2. 2

    Hypertension-mediated organ damage involving multiple sites is an independent risk factor for cardiovascular events.

    Lembo M, Pacella D, Manzi MV, et al.

    European heart journal open 2023; (3(5)):oead102 doi:10.1093/ehjopen/oead102.

    PMID: 37881599
  3. 3

    Hypertension mediated kidney and cardiovascular damage and risk stratification: Redefining concepts.

    Márquez DF, Rodríguez-Sánchez E, de la Morena JS, et al.

    Nefrologia 2022; (42(5)):519-530 doi:10.1016/j.nefroe.2021.10.008.

    PMID: 36792306
  4. 4

    Hypertension-mediated organ damage and established cardiovascular disease in patients with hypertension: the China Hypertension Survey, 2012-2015.

    Wang X, Hao G, Chen L, et al.

    Journal of human hypertension 2022; (36(12)):1092-1098 doi:10.1038/s41371-021-00635-z.

    PMID: 34799686
  5. 5

    Hypertension-Mediated Organ Damage: Prevalence, Correlates, and Prognosis in the Community.

    Vasan RS, Song RJ, Xanthakis V, et al.

    Hypertension (Dallas, Tex. : 1979) 2022; (79(3)):505-515 doi:10.1161/HYPERTENSIONAHA.121.18502.

    PMID: 35138872
  6. 6

    Frequency of laboratory testing and associated abnormalities in patients with hypertension.

    Quan S, Chen G, Padwal RS, et al.

    Journal of clinical hypertension (Greenwich, Conn.) 2020; (22(11)):2077-2083 doi:10.1111/jch.14040.

    PMID: 32951340
  7. 7

    Left ventricular hypertrophy detection using electrocardiographic signal.

    Liu CW, Wu FH, Hu YL, et al.

    Scientific reports 2023; (13(1)):2556 doi:10.1038/s41598-023-28325-5.

    PMID: 36781924
  8. 8

    Laboratory Assessment of Diabetic Kidney Disease.

    Narva AS, Bilous RW

    Diabetes spectrum : a publication of the American Diabetes Association 2015; (28(3)):162-6 doi:10.2337/diaspect.28.3.162.

    PMID: 26300608
  9. 9

    Gender-Adjustment and Cutoff Values of Cornell Product in Hypertensive Japanese Patients.

    Ishikawa J, Yamanaka Y, Toba A, et al.

    International heart journal 2017; (58(6)):933-938 doi:10.1536/ihj.16-573.

    PMID: 29162779
  10. 10

    The use of echocardiography compared to electrocardiogram when screening for left ventricular hypertrophy in hypertensive patients: A cross-sectional study.

    Bult MM, van de Ree TF, Wind AM, et al.

    Journal of clinical hypertension (Greenwich, Conn.) 2024; (26(8)):977-985 doi:10.1111/jch.14867.

    PMID: 38963706
  11. 11

    Discrepancy between left ventricular hypertrophy by echocardiography and electrocardiographic hypertrophy: clinical characteristics and outcomes.

    Seko Y, Kato T, Yamaji Y, et al.

    Open heart 2021; (8(2)) doi:10.1136/openhrt-2021-001765.

    PMID: 34556560
  12. 12

    Renal sympathetic activity: A key modulator of pressure natriuresis in hypertension.

    Díaz-Morales N, Baranda-Alonso EM, Martínez-Salgado C, López-Hernández FJ

    Biochemical pharmacology 2023; (208()):115386 doi:10.1016/j.bcp.2022.115386.

    PMID: 36535529
  13. 13

    Screening, identifying, and treating chronic kidney disease: why, who, when, how, and what?

    Farrell DR, Vassalotti JA

    BMC nephrology 2024; (25(1)):34 doi:10.1186/s12882-024-03466-5.

    PMID: 38273240
  14. 14

    Biomarkers in chronic kidney disease, from kidney function to kidney damage.

    Lopez-Giacoman S, Madero M

    World journal of nephrology 2015; (4(1)):57-73 doi:10.5527/wjn.v4.i1.57.

    PMID: 25664247
  15. 15

    Diagnostic Accuracy of Smartphone-Enabled Urinary Albumin-to-Creatinine Ratio Testing.

    Jeddah D, Bevins NB, Ronen M, et al.

    The journal of applied laboratory medicine 2025; (10(5)):1241-1253 doi:10.1093/jalm/jfaf087.

    PMID: 40643007
  16. 16

    Biological Variability of Estimated GFR and Albuminuria in CKD.

    Waikar SS, Rebholz CM, Zheng Z, et al.

    American journal of kidney diseases : the official journal of the National Kidney Foundation 2018; (72(4)):538-546 doi:10.1053/j.ajkd.2018.04.023.

    PMID: 30031564
  17. 17

    Incidence of and risk factors of chronic kidney disease: results of a nationwide study in Iceland.

    Jonsson AJ, Lund SH, Eriksen BO, et al.

    Clinical kidney journal 2022; (15(7)):1290-1299 doi:10.1093/ckj/sfac051.

    PMID: 35756731
  18. 18

    Prevention and treatment of hypertensive left ventricular hypertrophy.

    Tatavarthy M, Stathopoulos J, Oktay AA

    Current opinion in cardiology 2024; (39(4)):251-258 doi:10.1097/HCO.0000000000001135.

    PMID: 38603529

This page explains HMOD screening in essential hypertension for informational purposes only and does not constitute medical advice. Your clinician should interpret your ECG and kidney results and recommend care for your situation.

Get notified when new evidence is published on benign essential hypertension.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.